Trending menu:
News
-
18 October 2019
Worldwide selects ClinSpark eSource platform to automate trials
Worldwide Clinical Trials has implemented Foundry Health’s ClinSpark eSource Platform to automate Phase I first-in-human clinical trials for clinical development.
-
18 October 2019
Boehringer begins enrolment in Phase II BALANCE-CF1 trial
Boehringer Ingelheim has enrolled the first patient in the Phase II BALANCE-CF study investigating an inhaled epithelial sodium channel (ENaC) inhibitor, BI 1265162, to treat cystic fibrosis.
-
18 October 2019
Verona Pharma closes enrolment in Phase IIb COPD trial
UK-based biopharmaceutical firm Verona Pharma has completed patient enrolment in a Phase IIb clinical trial of nebulised ensifentrine (RPL554) to treat moderate-to-severe chronic obstructive pulmonary disease (COPD).
-
17 October 2019
doc.ai’s digital health trial to improve Epilepsy treatment
Healthcare startup doc.ai has launched the Epilepsy Digital Health Trial to improve treatment options for the condition and to test how artificial intelligence (AI) can help create a predictive and...
-
17 October 2019
Lilly’s pegilodecakin fails in Phase III pancreatic cancer trial
Eli Lilly has reported that the Phase III SEQUOIA clinical trial of pegilodecakin failed to meet the primary endpoint of overall survival in patients with metastatic pancreatic cancer.
-
17 October 2019
Novartis-Incyte’s Jakavi yields positive data in GvHD trial
Novartis and Incyte have reported positive results from the Phase III REACH2 clinical trial of Jakavi (ruxolitinib) conducted in steroid-refractory acute graft-versus-host disease (GvHD) patients.
-
17 October 2019
Noxxon Pharma studies combination therapy for brain cancer
Noxxon Pharma has commenced a Phase I/II clinical trial to assess its CXCL12 inhibitor, NOX-A12, in combination with external-beam radiotherapy to treat newly diagnosed brain cancer.
-
16 October 2019
PhaseBio doses first patient in ticagrelor antiplatelet activity trial
US-based clinical-stage biotechnology company PhaseBio Pharmaceuticals has dosed the first patient in a Phase IIb clinical trial of PB2452.
-
16 October 2019
Trialbee collaborates with TriNetX for patient-centric trials
Patient recruitment firm Trialbee has partnered with health research network TriNetX for data-driven digital solutions to speed-up patient-centric clinical trials.
-
16 October 2019
Replimune enrols first patient in Phase II CSCC study
Replimune Group has commenced patient enrolment in a Phase II clinical trial being conducted to assess its Immulytic product candidate RP1.